Replay_Logo_Black_CMYK.png
Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseases
21. November 2022 07:00 ET | Replay Bio
Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseases Second product company using Replay’s next-generation high payload capacity HSV delivery vector developed at...